Experts Discuss Clinical Application of TRK Inhibitors and Tumor Agnostic NTRK Fusion Testing

In this online educational program learn how to optimize oncology patient care by leveraging tumor-agnostic NTRK fusion testing and TRK inhibitors. Review expert insights on the latest data with an on-demand Webcast and downloadable slides from the live CCO symposium in Chicago.

Share

Program Content

Activities

Targeting TRK Fusions in Solid Tumors
Overview and Rationale for Targeting TRK Fusions in Solid Tumors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2019

Expires: June 02, 2020

Clinical Data on TRK Inhibitors
Clinical Data on TRK Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2019

Expires: June 02, 2020

<i>NTRK</i> Testing in the Clinic
Implementing NTRK Testing in the Clinic
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2019

Expires: June 02, 2020

Activities

Experts on TRK Inhibitors
Experts Discuss Clinical Application of TRK Inhibitors and Tumor Agnostic NTRK Fusion Testing
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2019

Expires: July 13, 2020

Faculty

cover img faculity

Todd M. Bauer, MD

Senior Investigator, Greco-Hainsworth Centers for Research
Tennessee Oncology, PLLC
Nashville, Tennessee

cover img faculity

Marcia Brose, MD, PhD, FASCO

Professor
Department of Medical Oncology
Sidney Kimmel Medical College
Thomas Jefferson University
Director, Sidney Kimmel Cancer Center
Vice Chair, Medical Oncology
Sidney Kimmel Medical College
Jefferson Northeast
Philadelphia, Pennsylvania

cover img faculity

George D. Demetri, MD

Professor of Medicine
Harvard Medical School
Harvard University
Co-Director, Ludwig Center at Harvard
Senior Vice President for Experimental Therapeutics
Director,
Sarcoma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma